during the swiftly evolving discipline of oncology investigation, accurate and economical mutation screening is critical for acquiring specific therapies. The KRAS solutions Platform performs a pivotal purpose in this landscape by presenting comprehensive methods for KRAS mutation profiling and Assessment. KRAS mutations, present in about ninety fi